What is BPC-157?
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein found naturally in human gastric juice. First isolated and characterised by researchers at the University of Zagreb, BPC-157 has been studied extensively in preclinical models for its remarkable ability to accelerate the healing of a wide variety of tissues, including muscle, tendon, ligament, bone, and gastrointestinal mucosa.
Unlike many peptides that target a single receptor, BPC-157 appears to exert its effects through multiple interconnected pathways. It upregulates growth factor expression (including VEGF, EGF, and TGF-beta), modulates nitric oxide synthesis, and interacts with the dopaminergic and GABAergic systems. This pleiotropic mechanism of action explains its broad therapeutic applications, from musculoskeletal injury recovery to inflammatory bowel conditions.
Evidence for Tissue Repair
Preclinical studies have demonstrated that BPC-157 accelerates tendon-to-bone healing, promotes angiogenesis (the formation of new blood vessels), and reduces inflammation at injury sites. In rat models of Achilles tendon transection, BPC-157-treated animals showed significantly improved tensile strength and faster functional recovery compared to controls. Similar results have been observed in models of muscle crush injury, ligament damage, and even peripheral nerve repair.
In the gastrointestinal tract, BPC-157 has shown cytoprotective and healing effects in models of inflammatory bowel disease, gastric ulcers, and NSAID-induced intestinal damage. Its ability to maintain mucosal integrity while promoting angiogenesis makes it a compelling candidate for patients with chronic gut inflammation or those recovering from GI procedures.
Clinical Use and Safety Considerations
While large-scale human randomised controlled trials are still underway, the preclinical evidence base for BPC-157 is extensive, spanning over 100 published studies. In clinical practice, BPC-157 is typically administered via subcutaneous injection near the site of injury, or systemically for gut-related applications. Dosing protocols vary, but common regimens range from 250–500 mcg once or twice daily for 4–8 week cycles.
- Derived from a naturally occurring gastric protective protein
- Promotes healing across muscle, tendon, ligament, and GI tissue
- Upregulates growth factors and modulates nitric oxide pathways
- Must be prescribed and monitored by a licensed healthcare provider
